Subpoenaed CTI's (Computerized Thermal Imaging's) cash dwindles after FDA rejection
This article was originally published in Clinica
Executive Summary
A cash crunch is among the problems faced by Computerized Thermal Imaging (CTI), which saw its available funds fall to less than $0.5m at the end of December. Earlier that month, the US FDA had refused to approve its infrared breast imaging system (see Clinica No 1037, p 13).